Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SSK vs SOLT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SOLT Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

SOLT Overall Winner 6-Pillar Tally: SSK 0 – 0 SOLT (6 Tie) Matrix Metrics: SSK 1 – 2 SOLT

As of Nov 16, 2026, 2x Solana ETF (SOLT) is the stronger overall head-to-head candidate over REX-Osprey SOL + Staking ETF (SSK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). SSK carries a Unified Composite Score of 40.7/100 (SELL) at $9.62 (N/M Forward P/E, N/A operating margin), whereas SOLT carries 44.3/100 (HOLD) at $25.96 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: SSK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 20.8); meanwhile SOLT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SSK vs SOLT
SSK Cboe BZX
REX-Osprey SOL + Staking ETF
Institutional Equity
$9.62
-10.59% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.80β · 53% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 21
RSI-14: 20.8 · SMA20: $12.59 · SMA50: $13.97
SOLT NASDAQ Head-to-Head Winner
2x Solana ETF
Institutional Equity
$25.96
-21.29% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.63β · 107% Vol
Unified Composite Score
44.3 / 100 HOLD
Tech 25.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 22
RSI-14: 22.2 · SMA20: $46.11 · SMA50: $58.19

6-Pillar Scorecard Institutional Category Breakdown (SSK 0 – 0 SOLT)

Columns: Metric · SSK · SOLT
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 70.4% (<1st %ile) 157.7% (52nd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SSK (1) vs SOLT (2)
Institutional Metric SSK SOLT Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
8% ($8–$24) 30% ($2–$82) Stronger Trend SOLT
Beta / 30D Volatility
Risk Regime
1.80β · 53% Vol 3.63β · 107% Vol Lower Realized Risk SSK
Unified Institutional Score
Composite Signal
40.7 / 100 (SELL) 44.3 / 100 (HOLD) Higher Composite SOLT
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SSK +23.26 pp
SSK: -31.09% · SOLT: -54.35%
3M Horizon SSK +17.07 pp
SSK: -7.77% · SOLT: -24.84%
6M Horizon SSK +27.45 pp
SSK: -16.35% · SOLT: -43.8%
1Y Horizon SOLT +235.49 pp
SSK: -56.05% · SOLT: +179.44%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SSK vs SOLT. Trailing 12-month operating profitability (SSK N/A vs SOLT N/A) and valuation multiples (SSK N/M vs SOLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SSK ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SOLT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SSK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 70.4%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SSK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SOLT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 157.7%
IV Percentile 52nd %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SOLT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SSK Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SOLT Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SSK vs SOLT Key Questions & Quantitative Answers

As of Nov 16, 2026, 2x Solana ETF (SOLT) is the stronger overall head-to-head candidate over REX-Osprey SOL + Staking ETF (SSK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). SSK carries a Unified Composite Score of 40.7/100 (SELL) at $9.62 (N/M Forward P/E, N/A operating margin), whereas SOLT carries 44.3/100 (HOLD) at $25.96 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: SSK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 20.8); meanwhile SOLT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SSK and SOLT split Growth & Scale metrics: SSK posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SOLT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SSK generates N/A in USD-normalized revenue versus N/A for SOLT. In operating R&D and SG&A reinvestment, SSK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SOLT.

SSK and SOLT trade at balanced relative valuation multiples. SSK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SOLT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SSK (N/A ROE) versus SOLT (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, SSK carries 70.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.80β · 53% Vol realized risk). By comparison, SOLT carries 157.7% implied volatility (52nd %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.63β · 107% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.